Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s10120-021-01206-4.

Title:
Establishment of oxaliplatin-resistant gastric cancer organoids: importance of myoferlin in the acquisition of oxaliplatin resistance | Gastric Cancer
Description:
Background The attainment of drug resistance in gastric cancer (GC) is a problematic issue. Although many studies have shown that cancer stem cells (CSCs) play an important role in the acquisition of drug resistance, there is no clinically available biomarker for predicting oxaliplatin (L-OHP) resistance in relation to CSCs. Organoid technology, a novel 3D cell culture system, allows harboring of patient-derived cancer cells containing abundant CSCs using niche factors in a dish. Methods In this study, we established L-OHP-resistant gastric cancer organoids (GCOs) and evaluated their gene expression profile using microarray analysis. We validated the upregulated genes in the L-OHP-resistant GCOs compared to their parental GCOs to find a gene responsible for L-OHP resistance by qRT-PCR, immunohistochemistry, in vitro, and in vivo experiments. Results We found myoferlin (MYOF) to be a candidate gene through microarray analysis. The results from cell viability assays and qRT-PCR showed that high expression of MYOF correlated significantly with the IC50 of L-OHP in GCOs. Immunohistochemistry of MYOF in GC tissue samples revealed that high expression of MYOF was significantly associated with poor prognosis, T grade, N grade, and lymphatic invasion, and showed MYOF to be an independent prognostic indicator, especially in the GC patients treated with platinum-based chemotherapy. The knockdown of MYOF repressed L-OHP resistance, cell growth, stem cell features, migration, invasion, and in vivo tumor growth. Conclusions Our results suggest that MYOF is highly involved in L-OHP resistance and tumor progression in GC. MYOF could be a promising biomarker and therapeutic target for L-OHP-resistant GC cases.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Education
  • Science
  • Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,626,932 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don’t know how the website earns money.

Websites don't always need to be profitable; some serve as platforms for education or personal expression. Websites can serve multiple purposes. And this might be one of them. Link.springer.com might be earning cash quietly, but we haven't detected the monetization method.

Keywords {🔍}

myof, gcos, lohp, cancer, expression, cell, fig, lohpresistant, cells, article, resistance, gastric, supplementary, google, scholar, analysis, organoids, tumor, assay, test, mkn, lines, cas, organoid, parental, invasion, patients, student, cscs, showed, cases, performed, gene, genes, results, growth, human, hiroshima, table, levels, data, research, myoferlin, shown, study, microarray, migration, normal, size, survival,

Topics {✒️}

r-spondin-producing cell line l-ohp-based therapeutic outcomes l-ohp-resistant gcos compared l-ohp-resistant gcos transduced k24 l-ohp-resistant gcos independent l-ohp-resistant gcos establish l-ohp-resistant gcos l-ohp-resistant gcos exhibited dna-damaging anti-cancer drugs k24 l-ohp-resistant gco l-ohp-resistant gc cases l-ohp-based treatment response stem cell-related markers patient-derived cancer cells exerts anti-tumor effects liver-intestine cadherin induction receiving platinum-based chemotherapy l-ohp-resistant gcos alter l-ohp sensitivity overcome l-ohp resistance approach l-ohp resistance reflects l-ohp resistance csc/epithelial-mesenchymal transition l-ohp-resistant gco received platinum-based chemotherapy receive platinum-based therapy dab substrate-chromogen solution human genome/gene research l-ohp administration timeline l-ohp treatment leads l-ohp gastric cscs l-ohp-resistant cscs drug-resistant cancer organoids cancer stem cell envision + anti-mouse full size image cancer stem cells phase-contrast microscopy anti-rabbit peroxidase triple-negative breast cancer l-ohp exerts cell stem cell organoid-based preclinical model elucidated 5-fu-resistant gcos kaplan–meier plotter database living organoid biobank human gastric cancer sustain stem cells gene expression profile l-ohp-resistant

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Establishment of oxaliplatin-resistant gastric cancer organoids: importance of myoferlin in the acquisition of oxaliplatin resistance
         description:The attainment of drug resistance in gastric cancer (GC) is a problematic issue. Although many studies have shown that cancer stem cells (CSCs) play an important role in the acquisition of drug resistance, there is no clinically available biomarker for predicting oxaliplatin (L-OHP) resistance in relation to CSCs. Organoid technology, a novel 3D cell culture system, allows harboring of patient-derived cancer cells containing abundant CSCs using niche factors in a dish. In this study, we established L-OHP-resistant gastric cancer organoids (GCOs) and evaluated their gene expression profile using microarray analysis. We validated the upregulated genes in the L-OHP-resistant GCOs compared to their parental GCOs to find a gene responsible for L-OHP resistance by qRT-PCR, immunohistochemistry, in vitro, and in vivo experiments. We found myoferlin (MYOF) to be a candidate gene through microarray analysis. The results from cell viability assays and qRT-PCR showed that high expression of MYOF correlated significantly with the IC50 of L-OHP in GCOs. Immunohistochemistry of MYOF in GC tissue samples revealed that high expression of MYOF was significantly associated with poor prognosis, T grade, N grade, and lymphatic invasion, and showed MYOF to be an independent prognostic indicator, especially in the GC patients treated with platinum-based chemotherapy. The knockdown of MYOF repressed L-OHP resistance, cell growth, stem cell features, migration, invasion, and in vivo tumor growth. Our results suggest that MYOF is highly involved in L-OHP resistance and tumor progression in GC. MYOF could be a promising biomarker and therapeutic target for L-OHP-resistant GC cases.
         datePublished:2021-07-16T00:00:00Z
         dateModified:2021-07-30T00:00:00Z
         pageStart:1264
         pageEnd:1277
         sameAs:https://doi.org/10.1007/s10120-021-01206-4
         keywords:
            Organoids
            Oxaliplatin
            Gastric cancer
            MYOF
            Surgical Oncology
            Oncology
            Abdominal Surgery
            Gastroenterology
            Cancer Research
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10120-021-01206-4/MediaObjects/10120_2021_1206_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10120-021-01206-4/MediaObjects/10120_2021_1206_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10120-021-01206-4/MediaObjects/10120_2021_1206_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10120-021-01206-4/MediaObjects/10120_2021_1206_Fig4_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10120-021-01206-4/MediaObjects/10120_2021_1206_Fig5_HTML.png
         isPartOf:
            name:Gastric Cancer
            issn:
               1436-3305
               1436-3291
            volumeNumber:24
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Singapore
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Kenji Harada
               affiliation:
                     name:Hiroshima University
                     address:
                        name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Naoya Sakamoto
               url:http://orcid.org/0000-0001-6273-0189
               affiliation:
                     name:Hiroshima University
                     address:
                        name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Shoichi Ukai
               affiliation:
                     name:Hiroshima University
                     address:
                        name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yusuke Yamamoto
               affiliation:
                     name:National Cancer Center Research Institute
                     address:
                        name:Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, Tokyo, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Quoc Thang Pham
               affiliation:
                     name:Hiroshima University
                     address:
                        name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Daiki Taniyama
               affiliation:
                     name:Hiroshima University
                     address:
                        name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ririno Honma
               affiliation:
                     name:Hiroshima University
                     address:
                        name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ryota Maruyama
               affiliation:
                     name:Hiroshima University
                     address:
                        name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Tsuyoshi Takashima
               affiliation:
                     name:Hiroshima University
                     address:
                        name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hiroshi Ota
               affiliation:
                     name:Hiroshima University
                     address:
                        name:Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yuki Takemoto
               affiliation:
                     name:Hiroshima University
                     address:
                        name:Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kazuaki Tanabe
               affiliation:
                     name:Hiroshima University
                     address:
                        name:Department of Health Care for Adults, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hideki Ohdan
               affiliation:
                     name:Hiroshima University
                     address:
                        name:Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Wataru Yasui
               affiliation:
                     name:Hiroshima University
                     address:
                        name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Establishment of oxaliplatin-resistant gastric cancer organoids: importance of myoferlin in the acquisition of oxaliplatin resistance
      description:The attainment of drug resistance in gastric cancer (GC) is a problematic issue. Although many studies have shown that cancer stem cells (CSCs) play an important role in the acquisition of drug resistance, there is no clinically available biomarker for predicting oxaliplatin (L-OHP) resistance in relation to CSCs. Organoid technology, a novel 3D cell culture system, allows harboring of patient-derived cancer cells containing abundant CSCs using niche factors in a dish. In this study, we established L-OHP-resistant gastric cancer organoids (GCOs) and evaluated their gene expression profile using microarray analysis. We validated the upregulated genes in the L-OHP-resistant GCOs compared to their parental GCOs to find a gene responsible for L-OHP resistance by qRT-PCR, immunohistochemistry, in vitro, and in vivo experiments. We found myoferlin (MYOF) to be a candidate gene through microarray analysis. The results from cell viability assays and qRT-PCR showed that high expression of MYOF correlated significantly with the IC50 of L-OHP in GCOs. Immunohistochemistry of MYOF in GC tissue samples revealed that high expression of MYOF was significantly associated with poor prognosis, T grade, N grade, and lymphatic invasion, and showed MYOF to be an independent prognostic indicator, especially in the GC patients treated with platinum-based chemotherapy. The knockdown of MYOF repressed L-OHP resistance, cell growth, stem cell features, migration, invasion, and in vivo tumor growth. Our results suggest that MYOF is highly involved in L-OHP resistance and tumor progression in GC. MYOF could be a promising biomarker and therapeutic target for L-OHP-resistant GC cases.
      datePublished:2021-07-16T00:00:00Z
      dateModified:2021-07-30T00:00:00Z
      pageStart:1264
      pageEnd:1277
      sameAs:https://doi.org/10.1007/s10120-021-01206-4
      keywords:
         Organoids
         Oxaliplatin
         Gastric cancer
         MYOF
         Surgical Oncology
         Oncology
         Abdominal Surgery
         Gastroenterology
         Cancer Research
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10120-021-01206-4/MediaObjects/10120_2021_1206_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10120-021-01206-4/MediaObjects/10120_2021_1206_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10120-021-01206-4/MediaObjects/10120_2021_1206_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10120-021-01206-4/MediaObjects/10120_2021_1206_Fig4_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10120-021-01206-4/MediaObjects/10120_2021_1206_Fig5_HTML.png
      isPartOf:
         name:Gastric Cancer
         issn:
            1436-3305
            1436-3291
         volumeNumber:24
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Singapore
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Kenji Harada
            affiliation:
                  name:Hiroshima University
                  address:
                     name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Naoya Sakamoto
            url:http://orcid.org/0000-0001-6273-0189
            affiliation:
                  name:Hiroshima University
                  address:
                     name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Shoichi Ukai
            affiliation:
                  name:Hiroshima University
                  address:
                     name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yusuke Yamamoto
            affiliation:
                  name:National Cancer Center Research Institute
                  address:
                     name:Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, Tokyo, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Quoc Thang Pham
            affiliation:
                  name:Hiroshima University
                  address:
                     name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Daiki Taniyama
            affiliation:
                  name:Hiroshima University
                  address:
                     name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ririno Honma
            affiliation:
                  name:Hiroshima University
                  address:
                     name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ryota Maruyama
            affiliation:
                  name:Hiroshima University
                  address:
                     name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Tsuyoshi Takashima
            affiliation:
                  name:Hiroshima University
                  address:
                     name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hiroshi Ota
            affiliation:
                  name:Hiroshima University
                  address:
                     name:Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yuki Takemoto
            affiliation:
                  name:Hiroshima University
                  address:
                     name:Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kazuaki Tanabe
            affiliation:
                  name:Hiroshima University
                  address:
                     name:Department of Health Care for Adults, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hideki Ohdan
            affiliation:
                  name:Hiroshima University
                  address:
                     name:Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Wataru Yasui
            affiliation:
                  name:Hiroshima University
                  address:
                     name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Gastric Cancer
      issn:
         1436-3305
         1436-3291
      volumeNumber:24
Organization:
      name:Springer Singapore
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Hiroshima University
      address:
         name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
         type:PostalAddress
      name:Hiroshima University
      address:
         name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
         type:PostalAddress
      name:Hiroshima University
      address:
         name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
         type:PostalAddress
      name:National Cancer Center Research Institute
      address:
         name:Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, Tokyo, Japan
         type:PostalAddress
      name:Hiroshima University
      address:
         name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
         type:PostalAddress
      name:Hiroshima University
      address:
         name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
         type:PostalAddress
      name:Hiroshima University
      address:
         name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
         type:PostalAddress
      name:Hiroshima University
      address:
         name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
         type:PostalAddress
      name:Hiroshima University
      address:
         name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
         type:PostalAddress
      name:Hiroshima University
      address:
         name:Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
         type:PostalAddress
      name:Hiroshima University
      address:
         name:Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
         type:PostalAddress
      name:Hiroshima University
      address:
         name:Department of Health Care for Adults, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
         type:PostalAddress
      name:Hiroshima University
      address:
         name:Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
         type:PostalAddress
      name:Hiroshima University
      address:
         name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Kenji Harada
      affiliation:
            name:Hiroshima University
            address:
               name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
               type:PostalAddress
            type:Organization
      name:Naoya Sakamoto
      url:http://orcid.org/0000-0001-6273-0189
      affiliation:
            name:Hiroshima University
            address:
               name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Shoichi Ukai
      affiliation:
            name:Hiroshima University
            address:
               name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
               type:PostalAddress
            type:Organization
      name:Yusuke Yamamoto
      affiliation:
            name:National Cancer Center Research Institute
            address:
               name:Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, Tokyo, Japan
               type:PostalAddress
            type:Organization
      name:Quoc Thang Pham
      affiliation:
            name:Hiroshima University
            address:
               name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
               type:PostalAddress
            type:Organization
      name:Daiki Taniyama
      affiliation:
            name:Hiroshima University
            address:
               name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
               type:PostalAddress
            type:Organization
      name:Ririno Honma
      affiliation:
            name:Hiroshima University
            address:
               name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
               type:PostalAddress
            type:Organization
      name:Ryota Maruyama
      affiliation:
            name:Hiroshima University
            address:
               name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
               type:PostalAddress
            type:Organization
      name:Tsuyoshi Takashima
      affiliation:
            name:Hiroshima University
            address:
               name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
               type:PostalAddress
            type:Organization
      name:Hiroshi Ota
      affiliation:
            name:Hiroshima University
            address:
               name:Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
               type:PostalAddress
            type:Organization
      name:Yuki Takemoto
      affiliation:
            name:Hiroshima University
            address:
               name:Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
               type:PostalAddress
            type:Organization
      name:Kazuaki Tanabe
      affiliation:
            name:Hiroshima University
            address:
               name:Department of Health Care for Adults, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
               type:PostalAddress
            type:Organization
      name:Hideki Ohdan
      affiliation:
            name:Hiroshima University
            address:
               name:Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
               type:PostalAddress
            type:Organization
      name:Wataru Yasui
      affiliation:
            name:Hiroshima University
            address:
               name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
      name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
      name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
      name:Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, Tokyo, Japan
      name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
      name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
      name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
      name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
      name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
      name:Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
      name:Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
      name:Department of Health Care for Adults, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
      name:Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
      name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan

External Links {🔗}(121)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

5.15s.